In addition, UCA1 overexpression resulted in down-regulation of miR-216b expression with a dose-dependent manner in HCC cells, suggesting that UCA1, which acted as an endogenous antagomir, could reduce miR-216b expression (Figure 4G). Here, UCA1 is linked to hepatocellular carcinoma.